Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., Cambridge, MA 02142, USA.
Rapid Commun Mass Spectrom. 2012 Feb 15;26(3):320-6. doi: 10.1002/rcm.5332.
Metabolite identification is an important part of the drug discovery and development process. High sensitivity is necessary to identify metabolic products in vitro and in vivo. The most common method utilizes standard high-performance liquid chromatography (4.6 mm i.d. column and 1 mL/min flow rate) coupled to tandem mass spectrometry (HPLC/MS/MS). We have developed a method that utilizes a nano-LC system coupled to a high-resolution tandem mass spectrometer to identify metabolites from in vitro and in vivo samples. Using this approach, we were able to increase the sensitivity of analysis by approximately 1000-fold over HPLC/MS. In vitro samples were analyzed after simple acetonitrile precipitation, centrifugation, and dilution. The significant improvement in sensitivity enabled us to conduct experiments at very low substrate concentrations (0.01 μM), and very low incubation volumes (20 μL). In vivo samples were injected after simple dilution without any pre-purification. All the metabolites identified by conventional HPLC/MS/MS were also identified using the nano-LC method. This study demonstrates a very sensitive approach to identifying phase I and II metabolites with throughput and separation equivalent to the standard HPLC/MS/MS method.
代谢产物鉴定是药物发现和开发过程中的一个重要部分。为了鉴定体外和体内的代谢产物,需要高灵敏度。最常用的方法是利用标准高效液相色谱(4.6mm内径柱和 1mL/min 流速)与串联质谱(HPLC/MS/MS)联用。我们开发了一种利用纳升液相色谱系统与高分辨率串联质谱联用的方法,从体外和体内样品中鉴定代谢产物。使用这种方法,我们能够将分析灵敏度提高约 1000 倍,超过 HPLC/MS。体外样品经过简单的乙腈沉淀、离心和稀释后进行分析。灵敏度的显著提高使我们能够在非常低的底物浓度(0.01 μM)和非常低的孵育体积(20 μL)下进行实验。体内样品在简单稀释后无需任何预纯化即可进样。使用传统的 HPLC/MS/MS 方法鉴定的所有代谢产物也可以使用纳升液相色谱法鉴定。这项研究展示了一种非常灵敏的方法,可以鉴定 I 相和 II 相代谢产物,其通量和分离效率与标准 HPLC/MS/MS 方法相当。